• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

老年急性髓系白血病的生物学特征与预后

Biological characteristics and prognosis of acute myeloid leukemia in elderly patients.

作者信息

Chen Zhe, Ding Lina, Yu Jieni, Jin Jing, Zhang Zhijian, Fu Jiaping, Hong Pan, Fu Leihua

机构信息

Department of Hematology, Shaoxing People's Hospital, Shaoxing, China.

出版信息

Front Genet. 2025 Apr 4;16:1524177. doi: 10.3389/fgene.2025.1524177. eCollection 2025.

DOI:10.3389/fgene.2025.1524177
PMID:40255482
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12006902/
Abstract

BACKGROUND

Our study aimed to investigate the effects of chromosomal aberrations and genetic mutations of elderly individuals diagnosed with AML and determine its prognostic significance.

METHODS

We retrospectively collected data over nearly 7 years from our hospital, encompassing 90 cases of elderly AML patients. Baseline information of patients was gathered and followed up, and statistical analysis was conducted using SPSS 25.0.

RESULTS

Among the 90 elderly non-M3 AML patients, 56 (62.2%) exhibited multiple gene mutations, with 9 (10%) patients displaying five or more gene mutations. The incidence of mutation was significantly higher in patients with normal karyotypes compared to those with abnormal karyotypes (P = 0.001). Patients with , , or mutations displayed lower rates of CR compared to wild-type counterparts. Kaplan-Meier analysis revealed that mutation (P = 0.0474), mutation (P = 0.0364), mutation (P = 0.0031), and 17p abnormality (P = 0.00285) were predictive of shorter OS. mutations (P = 0.0440), 17p abnormalities (P = 0.0272), 7q abnormalities (P = 0.0174), and complex karyotypes (P = 0.0447) were associated with shorter RFS.

CONCLUSION

Our findings suggest that elderly AML patients exhibit distinctive genetic profiles, and favorable prognosis genes do not seem to apply to elderly AML patients.

摘要

背景

我们的研究旨在调查老年急性髓系白血病(AML)患者的染色体畸变和基因突变情况,并确定其预后意义。

方法

我们回顾性收集了我院近7年的数据,包括90例老年AML患者。收集患者的基线信息并进行随访,使用SPSS 25.0进行统计分析。

结果

在90例老年非M3 AML患者中,56例(62.2%)表现出多种基因突变,其中9例(10%)患者有5种或更多基因突变。正常核型患者的突变发生率显著高于异常核型患者(P = 0.001)。与野生型相比,具有 、 或 突变的患者完全缓解(CR)率较低。Kaplan-Meier分析显示, 突变(P = 0.0474)、 突变(P = 0.0364)、 突变(P = 0.0031)和17p异常(P = 0.00285)预示总生存期(OS)较短。 突变(P = 0.0440)、17p异常(P = 0.0272)、7q异常(P = 0.0174)和复杂核型(P = 0.0447)与无复发生存期(RFS)较短相关。

结论

我们的研究结果表明,老年AML患者表现出独特的基因特征,有利预后基因似乎不适用于老年AML患者。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7f67/12006902/2594ffd1b071/fgene-16-1524177-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7f67/12006902/a1adf9650820/fgene-16-1524177-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7f67/12006902/5f112e260030/fgene-16-1524177-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7f67/12006902/2594ffd1b071/fgene-16-1524177-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7f67/12006902/a1adf9650820/fgene-16-1524177-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7f67/12006902/5f112e260030/fgene-16-1524177-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7f67/12006902/2594ffd1b071/fgene-16-1524177-g003.jpg

相似文献

1
Biological characteristics and prognosis of acute myeloid leukemia in elderly patients.老年急性髓系白血病的生物学特征与预后
Front Genet. 2025 Apr 4;16:1524177. doi: 10.3389/fgene.2025.1524177. eCollection 2025.
2
[Coexisting mutations in NPM1-mutated elderly adults with acute myeloid leukemia].[NPM1 突变的老年急性髓系白血病患者中的共存突变]
Zhonghua Yi Xue Za Zhi. 2019 Oct 29;99(40):3152-3157. doi: 10.3760/cma.j.issn.0376-2491.2019.40.006.
3
[Efficacy and Safety of Decitabine Combined with Modified CAG Regimen in Patients Aged ≥ 70 Years with Newly Diagnosed Acute Myeloid Leukemia].地西他滨联合改良CAG方案治疗≥70岁初诊急性髓系白血病患者的疗效与安全性
Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2023 Jun;31(3):633-642. doi: 10.19746/j.cnki.issn.1009-2137.2023.03.003.
4
[The Genetic and Prognostic Characteristics of AML-MRC Patients].[急性髓系白血病伴髓系肉瘤患者的遗传及预后特征]
Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2022 Feb;30(1):18-21. doi: 10.19746/j.cnki.issn.1009-2137.2022.01.004.
5
Clinical and molecular characteristics of acute myeloid leukemia and the dismal prognosis of mutations in a real-world setting.在真实世界环境中,急性髓系白血病的临床和分子特征与 突变的不良预后。
Hematology. 2023 Dec;28(1):2223866. doi: 10.1080/16078454.2023.2223866.
6
Correlation Analysis and Prognostic Impacts of Biological Characteristics in Elderly Patients with Acute Myeloid Leukemia.老年急性髓系白血病患者生物学特征的相关性分析及其预后影响。
Clin Interv Aging. 2022 Aug 7;17:1187-1197. doi: 10.2147/CIA.S375000. eCollection 2022.
7
Prognostic implications of NPM1 mutations and FLT3 internal tandem duplications in Egyptian patients with cytogenetically normal acute myeloid leukemia.NPM1突变和FLT3内部串联重复在埃及细胞遗传学正常的急性髓系白血病患者中的预后意义
Hematology. 2014 Jan;19(1):22-30. doi: 10.1179/1607845413Y.0000000085. Epub 2013 Nov 25.
8
[Clinical Characteristics and Prognostic Relevance of Co-Mutated Genes in Acute Myeloid Leukemia Patients with Mutations].[急性髓系白血病患者共突变基因的临床特征及预后相关性研究]
Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2024 Aug;32(4):1032-1038. doi: 10.19746/j.cnki.issn.1009-2137.2024.04.009.
9
FMS-Like Tyrosine Kinase 3 (FLT3) and Nucleophosmin 1 (NPM1) in Iranian Adult Acute Myeloid Leukemia Patients with Normal Karyotypes: Mutation Status and Clinical and Laboratory Characteristics.伊朗正常核型成年急性髓系白血病患者中FMS样酪氨酸激酶3(FLT3)和核仁磷酸蛋白1(NPM1):突变状态及临床和实验室特征
Turk J Haematol. 2017 Dec 1;34(4):300-306. doi: 10.4274/tjh.2016.0489. Epub 2017 Mar 15.
10
[Analysis of Gene Mutation Characteristics and Prognosis of Elderly Patients with Acute Myeloid Leukemia].老年急性髓系白血病患者基因突变特征及预后分析
Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2022 Jun;30(3):755-759. doi: 10.19746/j.cnki.issn.1009-2137.2022.03.015.

本文引用的文献

1
The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Myeloid and Histiocytic/Dendritic Neoplasms.世界卫生组织血液淋巴肿瘤分类第五版:髓系和组织细胞/树突状肿瘤。
Leukemia. 2022 Jul;36(7):1703-1719. doi: 10.1038/s41375-022-01613-1. Epub 2022 Jun 22.
2
Racial and Ethnic Differences in Rural-Urban Trends in 5-Year Survival of Patients With Lung, Prostate, Breast, and Colorectal Cancers: 1975-2011 Surveillance, Epidemiology, and End Results (SEER).农村-城市地区肺癌、前列腺癌、乳腺癌和结直肠癌患者 5 年生存率的城乡趋势的种族和民族差异:1975-2011 年监测、流行病学和最终结果(SEER)。
JAMA Netw Open. 2022 May 2;5(5):e2212246. doi: 10.1001/jamanetworkopen.2022.12246.
3
Independent prognostic significance of TP53 mutations in adult acute myeloid leukaemia with complex karyotype.
复杂核型成人急性髓系白血病中 TP53 突变的独立预后意义。
Int J Lab Hematol. 2022 Oct;44(5):892-899. doi: 10.1111/ijlh.13864. Epub 2022 May 3.
4
Impact of FLT3 internal tandem duplication and NPM1 mutations in acute myeloid leukemia treated with allogeneic hematopoietic cell transplantation.FLT3内部串联重复和NPM1突变对接受异基因造血细胞移植治疗的急性髓系白血病的影响。
Cytotherapy. 2022 Apr;24(4):413-420. doi: 10.1016/j.jcyt.2021.10.006. Epub 2021 Dec 2.
5
Risk factors affect accurate prognosis in ASXL1-mutated acute myeloid leukemia.风险因素影响ASXL1突变型急性髓系白血病的准确预后。
Cancer Cell Int. 2021 Oct 9;21(1):526. doi: 10.1186/s12935-021-02233-y.
6
FLT3 mutated acute myeloid leukemia: 2021 treatment algorithm.FLT3 突变型急性髓系白血病:2021 年治疗算法。
Blood Cancer J. 2021 May 27;11(5):104. doi: 10.1038/s41408-021-00495-3.
7
De novo acute myeloid leukemia: A population-based study of outcome in the United States based on the Surveillance, Epidemiology, and End Results (SEER) database, 1980 to 2017.新发急性髓系白血病:基于美国监测、流行病学和最终结果(SEER)数据库的 1980 年至 2017 年的人群研究结果
Cancer. 2021 Jun 15;127(12):2049-2061. doi: 10.1002/cncr.33458. Epub 2021 Apr 5.
8
NCCN Guidelines Insights: Acute Myeloid Leukemia, Version 2.2021.NCCN 指南解读:急性髓系白血病,第 2.2021 版。
J Natl Compr Canc Netw. 2021 Jan 6;19(1):16-27. doi: 10.6004/jnccn.2021.0002.
9
Characteristics and prognostic significance of genetic mutations in acute myeloid leukemia based on a targeted next-generation sequencing technique.基于靶向二代测序技术的急性髓细胞白血病基因突变的特征及其预后意义。
Cancer Med. 2020 Nov;9(22):8457-8467. doi: 10.1002/cam4.3467. Epub 2020 Sep 24.
10
The global burden and attributable risk factor analysis of acute myeloid leukemia in 195 countries and territories from 1990 to 2017: estimates based on the global burden of disease study 2017.全球 195 个国家和地区 1990 年至 2017 年急性髓系白血病的全球负担和归因风险因素分析:基于 2017 年全球疾病负担研究的估计。
J Hematol Oncol. 2020 Jun 8;13(1):72. doi: 10.1186/s13045-020-00908-z.